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Adenocarcinoma of the prostate is an epithelial malig-
nancy that occurs in aging men. Th  e normal prostatic 
epithelium is a pseudostratiﬁ  ed epithelium with secretory 
luminal cells and interspersed basal cells. Prostate cancer 
generally exhibits a luminal cell morphology with a distinct 
absence of basal cells. Tumors are often multi  focal and 
exhibit considerable variation in histologic morphology 
and grade [1,2]. Th   e present study identiﬁ  ed a select group 
of basal cells with stem cell properties in the mouse 
prostate that is capable of cancer initiation following 
oncogenic transformation. Th   e resulting tumors exhibit a 
range of histologic morphologies – depend  ing upon the 
genetic mutations introduced – that phenocopy the varied 
appearance of human prostate cancer. Th   is is an intriguing 
observation showing that the same cell of origin can yield a 
range of tumor morpho  logies and grades depending on 
the genetic changes inﬂ  icted.
In a related study, Shen and colleagues reported that a 
rare population of castration-resistant NKx3.1-expres  s-
ing cells with stem cell characteristics is capable of 
initiating formation of carcinoma upon deletion of the 
tumor suppressor gene PTEN [3]. Th  ere is strong 
evidence for the existence of tissue-speciﬁ  c stem cells in 
the prostate, capable of self-renewal and diﬀ  erentiation 
into the full range of prostate epithelial cell types [4,5], 
and it has been speculated that these stem cells and/or 
closely related progenitor cells may be the progenitor for 
human prostate cancer. Th   e work on tissue-speciﬁ  c stem 
cells in the prostate lends credence to that speculation, 
and resonates with a previous report that cells present in 
normal human prostate epithelium with a basal 
phenotype and stem cell properties are also present in 
human prostate cancer [6]. Th   ere is as yet, however, no 
conclusive evidence that stem/progenitor cells are in fact 
the source of human prostate cancer.
Th  e multicentric and variegated histology of prostate 
cancer within a single prostate gland makes identifying 
the cell of origin a complicated and daunting challenge. 
Do the multicentric lesions share a common origin? Does 
prostate cancer begin as a low-grade lesion that spins oﬀ   
successively higher-grade tumor clones? Or do multiple 
low-grade and high-grade lesions arise independently 
within the same gland? Obviously, the answers to these 
questions will determine how we interpret studies 
examining the tumor-forming ability in a mouse model.
Recent work has implicated chronic inﬂ  ammation in the 
genesis of prostate cancer [7,8]. Areas of chronic inﬂ  am-
mation associated with atrophic-appearing yet hyperproli-
ferative epithelium (proliferative inﬂ  ammatory  atrophy) 
commonly appear in association with foci of prostatic 
intraepithelial neoplasia and cancer in the peripheral zone 
of the prostate [9]. Th  is has led to speculation that the 
origin of cancer is the proliferative epithelium in these 
atrophic glands. Th  e correlation of the basal cells in the 
present study by Witte and colleagues or of the luminal 
cells in the study by Shen and colleagues to the epithelial 
cells in proliferative inﬂ  ammatory atrophy is unknown but 
is an intriguing question.
Finally, it must be noted that a weakness of all animal-
based studies focusing on tumor formation is a deﬁ  nition 
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© 2010 BioMed Central Ltdof prostate cancer that is inherently incomplete. Human 
prostate cancer is deﬁ  ned not only by histologic criteria 
but also by a natural history that includes local invasion, 
characteristic patterns of lymph node and bone meta-
stasis and a general pattern of initial androgen depen-
dence giving way to androgen independence in advanced 
disease [1,2]. Th  e ﬁ   nding that genetic altera  tions of a 
select group of basal cells produces prostate lesions with 
variation in histological morphology that resemble 
various grades of prostate cancer is a powerful obser-
vation – but an observation that needs correlative studies 
with the process of oncogenesis in the human prostate 
and also further studies to elucidate the natural history 
and androgen dependence of the tumors generated by 
this approach.
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